This biotech stock is focused on developing solutions to treat people with liver cancer. It also has a market capitalisation of $1.5 billion. https://www.moneymag.com.au/feed/latest?story=141385872 en-AU Copyright 2026 Money magazine 5 https://media.moneymag.com.au/prod/media/library/Money_Mag/Logo/Logo_401x133.png